The Recall Desk
SevereFDA (Drugs)·D-0866-2018·Announced 2018-05-16

AuroMedics Recalls Ampicillin and Sulbactam Injection Due to Particulate Matter

AuroMedics Pharma LLC is recalling 54,720 vials of Ampicillin and Sulbactam for Injection due to confirmed reports of visible red rubber particles.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.

Plain-English summary

AuroMedics Pharma LLC is recalling 54,720 vials of Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial. The product is intended for intramuscular or intravenous use and was distributed nationwide in the USA and Puerto Rico. The specific lots affected are AS0317041-A and AS0317035-A, which have an expiration date of August 2019.

The recall was initiated due to a confirmed customer report of visible particulate matter in the product. The particles are believed to be red rubber originating from the manufacturing process of the active ingredients. The product is manufactured for AuroMedics Pharma LLC and carries the NDC 55150-117-20.

Healthcare providers and patients should stop using the affected lots immediately. Consumers should check their medication vials for the specific lot numbers and expiration dates listed above. If the product matches the recalled description, it should be returned to the pharmacy or healthcare provider for disposal or replacement.

The recalled product

Product
AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM)
Brand
AMPICILLIN AND SULBACTAM
Affected units
54,720

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot #: AS0317041-A
  • AS0317035-A
  • Exp August 2019

UPCs (4)

  • 0355150116201
  • 0355150179992
  • 0355150178995
  • 0355150117208

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Same brand · AMPICILLIN AND SULBACTAM